Dr Samantha Oakes
Director, Research Investment, National Breast Cancer Foundation
Dr Samantha Oakes brings 20 years’ experience of breast cancer research to the role of Director, Research Investment at National Breast Cancer Foundation (NBCF). After beginning her scientific career in 2001 at the Garvan Institute, she was awarded her PhD in 2007 (funded by NHMRC and NBCF fellowships) and received the ‘Garvan Institute Best Thesis Prize’ for her work understanding the role of the pituitary hormone prolactin in basal breast cancer.
In 2008, Samantha was awarded an NBCF Early Career Fellowship to further her studies at the Walter and Eliza Hall Institute (WEHI). Her work focussed on understanding how specialised signals in breast cancer cells prevent them from dying. She later showed that by turning these signals off, triple negative breast cancers could be sensitised to routine chemotherapy. In 2012, Samantha returned to the Garvan Institute to establish her own laboratory and together with her team, discovered a new dual therapeutic and anti-metastatic strategy for triple negative breast cancer.
In addition to her science, Samantha is a passionate advocate of breast cancer research in the community and via her new role as Director, Research Investment at NBCF, she hopes to influence and shape the breast cancer landscape in Australia and head towards a future of zero deaths from breast cancer.
Wednesday 22 September